NeuroSense Therapeutics and PhaseV have partnered to use causal machine learning to analyze and optimize the planned Phase 3 trial of PrimeC as a…
Browsing: ALS
NeuroSense partners with PhaseV to use advanced causal machine learning in their upcoming Phase 3 trial for PrimeC as a treatment for ALS. PhaseV’s…
ASU researchers are using AI and machine learning to analyze speech patterns and diagnose neurological conditions like Alzheimer’s, Parkinson’s, and ALS. They are also…
With iOS 17, Apple has introduced a feature called Personal Voice which uses on-device machine learning to recreate a user’s voice. This feature has…